Page 12 - Read Online
P. 12
Miller et al. Mini-invasive Surg 2021;5:24 https://dx.doi.org/10.20517/2574-1225.2021.25 Page 5 of 12
Table 2. Oncologic outcomes from selected studies after robot-assisted radical cystectomy
Ref. and study acronym Year Surgical approach Cases, (n) PSM, n (%) Lymph node yield, mean (SD) or median (IQR or range) RFS CSS OS
Comparative studies, randomized
[6,7]
RAZOR trial, multiple authors 2020, 2018 ORC 152 7 (5) 25.7 (SD 14.5) 65%, 3 yr nr 69%, 3 yr
RARC 150 9 (6) 23.3 (SD 12.5) 68%, 3 yr nr 74%, 3 yr
[8]
CORAL trial, Khan et al. 2020 ORC 20 2 (10) 18.5 (IQR 14-25) 60%, 5 yr 64%, 5 yr 55%, 5 yr
RARC 20 3 (15) 14.5 (IQR 11-21) 58%, 5 yr 68%, 5 yr 65%, 5 yr
LRC 19 1 (5) 15.5 (IQR 12-22) 71%, 5 yr 69%, 5 yr 61%, 5 yr
[9] # #
Bochner et al. 2018 ORC 58 3 (5) 29 (IQR 22-38) 59%, 5 yr 80%, 5 yr 65%, 5 yr
# #
RARC 60 2 (3) 31 (IQR 23-37) 64%, 5 yr 75%, 5 yr 65%, 5 yr
[10]
Parekh et al. 2012 ORC 20 1 (5) 23 (IQR 15-28) nr nr nr
RARC 20 1 (5) 11 (IQR 9-22) nr nr nr
[11]
Nix et al. 2010 ORC 20 0 (0) 18 (range 8-30) nr nr nr
RARC 21 0 (0) 19 (range 12-30) nr nr nr
Comparative studies, non-randomized
[12]
RACE study, Wijburg et al. 2021 ORC 168 nr (18)* 13 (IQR 9-18) 75%, 1 yr nr nr
RARC 180 nr (6) 15 (IQR 11-21) 76%, 1 yr nr nr
[13]
Asil et al. 2021 ORC 31 1 (3) 22 (nr) nr nr nr
RARC 61 9 (15) Range 22-25 nr nr nr
[14] # #
Ip et al. 2020 ORC 159 23 (14) 20 (SD 14)* 75%, 5 yr nr 65%, 5 yr
# #
RARC 73 8 (11) 12 (SD 8) 80 %, 5 yr nr 70%, 5 yr
[15]
Zhang et al. 2020 ORC 272 22 (8) nr nr nr 55%, 5 yr
RARC 676 34 (5) nr nr nr 58%, 5 yr
[16]
Faraj et al. 2019 ORC 278 15 (5) 12 (IQR 9-18)* 63%, 10 yr nr 46%, 10 yr
RARC 203 7 (3) 18 (IQR 14-24) 70%, 10 yr nr 40%, 10 yr
[17]
Moschini et al. 2019 ORC 1666 160 (10) 16 (10-24) nr nr nr
RARC 870 112 (13) 18 (12-25) nr nr nr
[18]
Simone et al. 2018 RARC, ICUD only 64 0 (0) 33.4 (SD 12.3) 79%, 4 yr 85%, 4 yr 82%, 4 yr
ORC 46 0 (0) 31.3 (SD 14.6) 73%, 4 yr 86%, 4 yr 80%, 4 yr
[19]
Hanna et al. 2018 ORC 7513 (10.7) 12 (IQR 7-20)* nr nr nr
RARC 2048 (9.3) 17 (IQR 10-25) nr nr nr
[20]
Gandagli et al. 2016 ORC 230 31 (13) 13 (IQR 9-17) 57%, 5 yr 62%, 5 yr 58%, 5 yr
RARC 138 12 (9) 12 (IQR 8-17) 54%, 5 yr 74%, 5 yr 59%, 5 yr
[21]
Tan et al. 2016 ORC 90 17 (19)* 12.6 (SD 10.9) 70%, 2 yr 81%, 2 yr 74%, 2 yr
